NOTICE OF INTENT TO AWARD SOLE SOURCE -Preventative Maintenance service and unlimited repairs as needed on two Illumina MiSeq Whole Genome Sequencer Instruments

NOTICE OF INTENT TO AWARD SOLE SOURCE Project Title: FDA-24- 1272751 – Preventative Maintenance service and unlimited repairs as needed on two Illumina MiSeq Whole Genome Sequencer Instruments Announcement No : FDA-24- 272751 The Government hereby submits a notice of intent to award a sole source contract to Illumina for Preventative Maintenance service and unlimited repairs as needed on two Illumina MiSeq Whole Genome Sequencer Instruments. The total estimated value is less than $171K. This sole source contracting action a notice pursuant to FAR 5.203(a) for the requirement based on the application of FAR 6.302-1. This hereby constitutes a synopsis of this requirement. This is an award under NAICS Code 334516. Illumina is the sole-source vendor for preventative maintenance on the current Illumina MiSeq Whole Genome Sequencer Instrument and is also the only vendor that can provide proprietary􀀃technology and validated parts necessary for replacement or repair on the current machine. To ensure that the Illumina MiSeq Whole Genome Sequencer Instruments maintains its instrument qualifications this procurement should be sole sourced to Illumina. Responses to this notice must demonstrate clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and would not hinder the mission objective of the FDA. The determination not to compete this proposed contract action solely within the discretion of the Government. Information received will normally be considered for the purposes of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice. This is NOT a request for quotes or proposals. Questions or comments to this Notice of Intent should be directed to Contract Specialist, Elena Tatarov, at [email protected] (via email only) and within 7 days of the notice of intent posting date. Please be advised no phone calls/voice mail messages regarding questions will be accepted and nor will they receive a response. Please indicate in the subject line of your email: Notice of Intent Questions Submission – FDA-24- 1272751.